Prevalence of HLA sensitization in female apheresis donors.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMID 9920173)

Published in Transfusion on January 01, 1999

Authors

T L Densmore1, L T Goodnough, S Ali, M Dynis, H Chaplin

Author Affiliations

1: Department of Pathology, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri, USA.

Articles citing this

Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med (2007) 3.69

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (2009) 2.56

Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol (2009) 1.23

Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion (2010) 1.01

Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion (2008) 0.94

TRALI--definition, mechanisms, incidence and clinical relevance. Best Pract Res Clin Anaesthesiol (2007) 0.92

The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion (2010) 0.89

Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation. Br J Haematol (2014) 0.87

Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components. Transfus Med (2007) 0.86

Pregnancy-Induced Sensitization Promotes Sex Disparity in Living Donor Kidney Transplantation. J Am Soc Nephrol (2017) 0.86

The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang (2011) 0.86

Female donors and transfusion-related acute lung injury: A case-referent study from the International TRALI Unisex Research Group. Transfusion (2010) 0.82

Acute respiratory distress syndrome: prevention and early recognition. Ann Intensive Care (2013) 0.81

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation. Adv Hematol (2016) 0.80

Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused Patients. Indian J Hematol Blood Transfus (2014) 0.78

Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay. Transfus Med (2009) 0.78

Experimental models of transfusion-related acute lung injury. Transfus Med Rev (2011) 0.78

The approach taken to reducing the risk of transfusion related acute lung injury in Canada. Asian J Transfus Sci (2008) 0.78

Long-Term follow up after intra-Uterine transfusionS; the LOTUS study. BMC Pregnancy Childbirth (2010) 0.78

The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil. Transfus Apher Sci (2012) 0.78

Platelet kinetics after slow versus standard transfusions: a pilot study. Ups J Med Sci (2011) 0.75

TRALI in Perioperative Period-A Case Report. Indian J Anaesth (2009) 0.75

Transfusion Related Acute Lung Injury (TRALI): A Single Institution Experience of 15 Years. Indian J Hematol Blood Transfus (2015) 0.75

Articles by these authors

Wind-driven upwelling in the Southern Ocean and the deglacial rise in atmospheric CO2. Science (2009) 5.36

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem (2001) 3.86

Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55

DNA finger printing by oligonucleotide probes specific for simple repeats. Hum Genet (1986) 3.41

The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion (1994) 3.03

Prudent strategies for elective red blood cell transfusion. Ann Intern Med (1992) 2.98

Missed appointments in general practice: retrospective data analysis from four practices. Br J Gen Pract (2001) 2.33

Src tyrosine kinase is a novel direct effector of G proteins. Cell (2000) 2.26

Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet (2001) 2.22

Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis (1993) 2.19

Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res (2001) 2.15

Aprotinin prolongs whole blood activated partial thromboplastin time but not whole blood prothrombin time in patients undergoing cardiac surgery. Anesth Analg (1995) 2.06

A new era in blood conservation. Ann Thorac Surg (1991) 2.05

Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol (2001) 2.01

Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion (1998) 1.93

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84

The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1995) 1.80

Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell (2000) 1.77

An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics (2002) 1.73

Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion (1985) 1.71

Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res (1992) 1.68

Proteinuria in obstructive sleep apnea. Kidney Int (2001) 1.66

Packed red blood cells. N Engl J Med (1969) 1.60

Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol (1999) 1.60

Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion (1995) 1.59

Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg (1997) 1.56

Characterization of surface properties of Vibrio cholerae. Infect Immun (1983) 1.50

A stroke unit in a district general hospital: the Greenwich experience. Br Med J (1979) 1.50

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48

Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses. Ann Thorac Surg (1996) 1.48

Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants. J Hosp Infect (2011) 1.48

Leukocyte reduction in blood component therapy. Ann Intern Med (1992) 1.44

Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem (1997) 1.42

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen (2007) 1.41

Surma--a toxic cosmetic? J Pak Med Assoc (1988) 1.41

A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41

Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid. J Eur Acad Dermatol Venereol (2003) 1.40

The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med (1994) 1.40

Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40

Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A (1991) 1.40

Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant (2000) 1.39

Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients. Transfusion (1991) 1.39

Hairy canals and hair removal cream. Clin Otolaryngol (2008) 1.38

A standardized method for calculating blood loss. Transfusion (1997) 1.37

Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology (1996) 1.37

Does exclusion of enteral lipid assist remission in Crohn's disease? J Clin Gastroenterol (1993) 1.37

Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res (1993) 1.37

Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem (1995) 1.36

The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion (1993) 1.34

Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med (1967) 1.34

Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol (1992) 1.27

Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program. Vox Sang (1999) 1.27

Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol (2001) 1.25

Ecological analysis of ethnic differences in relation between tuberculosis and poverty. BMJ (1999) 1.22

Role of Host Sensitivity to Ptr ToxA in Development of Tan Spot of Wheat. Phytopathology (2003) 1.22

The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem (2001) 1.22

Anemia, transfusion, and mortality. N Engl J Med (2001) 1.21

First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21

The organization of the evolutionarily conserved GATA/GACA repeats in the mouse genome. Chromosoma (1986) 1.20

Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood (2001) 1.20

Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. Endocr Relat Cancer (2006) 1.20

Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. Int J Obstet Anesth (2009) 1.19

Pregnancy and idiopathic autoimmune haemolytic anaemia: a prospective study during 6 months gestation and 3 months post-partum. Br J Haematol (1973) 1.19

Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang (2009) 1.19

The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene (2009) 1.19

Population Genetic Analysis of a Global Collection of Pyrenophora tritici-repentis, Causal Agent of Tan Spot of Wheat. Phytopathology (2005) 1.18

Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem (1995) 1.18

An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer (1998) 1.17

Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ (2005) 1.17

Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem (1994) 1.17

Expression of two forms of prolactin receptor in rat ovary and liver. Mol Endocrinol (1990) 1.17

Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion (2001) 1.16

Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol (1992) 1.16

Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene (2009) 1.16

A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology (1997) 1.16

Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol (1995) 1.15

Regulation of ROMK1 channels by protein-tyrosine kinase and -tyrosine phosphatase. J Biol Chem (2000) 1.15

Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem (1994) 1.14

False-positive and false-negative neck nodes. Head Neck Surg (1986) 1.13

Magic-angle spinning NMR studies of molecular organization in multibilayers formed by 1-octadecanoyl-2-decanoyl-sn-glycero-3-phosphocholine. Biophys J (1990) 1.13

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer (1984) 1.12

Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures. Transbound Emerg Dis (2012) 1.11

The growth hormone/prolactin receptor family. Recent Prog Horm Res (1993) 1.11

Atypical antigenic properties of a gamma-A myeloma protein. J Immunol (1966) 1.11

Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) (1983) 1.09

Valproate in the treatment of persistent chronic daily headache. An open label study. Headache (1991) 1.08

Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews. Int J Qual Health Care (1996) 1.08

The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol (1989) 1.08

Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion (1992) 1.07

Stratifying patients preoperatively for transfusion outcomes. Ann Thorac Surg (1996) 1.07

Tuberculoma of the brain: a series of 16 cases treated with anti-tuberculosis drugs. Int J Tuberc Lung Dis (2007) 1.07

Novel inner monolayer fusion assays reveal differential monolayer mixing associated with cation-dependent membrane fusion. Biochim Biophys Acta (2000) 1.07

Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med (1981) 1.06

Complications following accidental administration of 1.5% glycine intravenously. Acta Anaesthesiol Scand (2008) 1.06

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg (1994) 1.06

Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures. J Immunol (1977) 1.05

VEGF polymorphisms and severity of atherosclerosis. J Med Genet (2005) 1.05